Terms: = Prostate cancer AND HSP90AB1, HSPCB, 3326, ENSG00000096384, HSP90B, HSP90-BETA, P08238, D6S182, HSPC2, FLJ26984 AND Prognosis
3 results:
1. PARP1 negatively regulates transcription of BLM through its interaction with hsp90ab1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract] [Full Text] [Related]
2. Factors associated with being diagnosed with high severity of breast cancer: a population-based study in Queensland, Australia.
Kou K; Cameron J; Aitken JF; Youl P; Turrell G; Chambers S; Dunn J; Pyke C; Baade PD
Breast Cancer Res Treat; 2020 Dec; 184(3):937-950. PubMed ID: 32926317
[TBL] [Abstract] [Full Text] [Related]
3. Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.
Xiang Y; Zhang L; Huang Y; Ling J; Zhuo W
Environ Toxicol Pharmacol; 2019 May; 68():141-147. PubMed ID: 30897525
[TBL] [Abstract] [Full Text] [Related]
